Cancer52sitelogo_edited.png
  • Home

  • Cancer52

    • About
    • Leadership Team
    • Policy Team
    • Data Team
    • Governance
    • Support Our Work
    • Collaborations & Supporters
    • Supporting Cancer Alliances
  • Members

    • Our Members
    • Members Area
  • Voice

    • Our Voice
    • Reports & Films
    • Consultations
    • Briefing Papers
  • Links

  • News

    • Latest News
    • Events
  • Contact

  • More

    Use tab to navigate through the menu items.
    DONATE
    OCV 10 Year Cancer Pan Consensus Stateme
    National Data Opt-out and what it means to cancer patients

    National Data Opt-out and what it means to cancer patients

    Cancer52, together with use MY data, has produced a briefing paper entitled National Data Opt-out and what it means to cancer patients....

    Cancer Strategy recommendations grid April

    As at April 2017, Cancer52 has published a review of the progress of the recommendations contained in ‘Achieving World Class Cancer...

    Briefing paper on the New Cancer Drug Fund Operating Model

    On 28th July 2016 Cancer52 published its Cancer52 Position Paper on the new Cancer Drugs Fund Operating Model FINAL 28th July 2016.

    Briefing paper on England Cancer Strategy Implementation Plan

    On 22nd June 2016 Cancer52 published its Cancer52 position statement Cancer Implementation Plan June 2016 FINAL.

    Briefing paper on Access to Medicines and Treatments

    On 23rd December 2015, Cancer52 published its Briefing Paper on Access to Medicines and Treatments.
    Policy briefing on Achieving World Class Outcomes

    Policy briefing on Achieving World Class Outcomes

    A briefing on the implementation of Achieving World Class Outcomes: A Strategy for England 2015-2020.

    Briefing paper on Access to Orphan Medicines in the UK

    On 5th June 2014, Cancer52 published its Briefing Paper on Access to Orphan Medicines in the UK.

    Briefing paper on the UK Strategy for Rare Diseases: Making sure that rare cancers aren’t written ou

    On 24th February 2014, Cancer52 published its Briefing Paper on the UK Strategy for Rare Diseases.

    Briefing paper on NICE and Value Based Assessment (VBA)

    On 21st February 2014, Cancer52 published its Briefing Paper "VBA: NICE do it their way".

    Briefing paper on Value Based Pricing and Cancer Drugs Fund

    On 20th September 2013, Cancer52 published Briefing Papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF); alongside an...
    1
    2
    • Twitter
    • Facebook

    info@cancer52.org.uk

    Terms & conditions • Cookie policy  •  Privacy policy

    Copyright © Cancer52. All rights reserved.

    Cancer52 is registered as a charity in England and Wales (1174569) and a company limited by guarantee in England and Wales (7994413)